India to Australia: Hydrocortisone Export Trade Route

The India to Australia Hydrocortisone corridor is one of India's established pharmaceutical export routes, with 130 shipments documented worth a combined $2.9M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 49% of all export value, reflecting the consolidated nature of India's hydrocortisone manufacturing sector.

Across 13 active suppliers, the average shipment value stands at $22.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with hydrocortisone's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 23.6%, placing it at rank #2 among India's top hydrocortisone export destinations globally.

On the import side, key buyers of Indian hydrocortisone in Australia include ECHO THERAPEUTICS, ECHO THERAPEUTICS , NOVA PHARMACEUTICALS AUSTRALASIA PT and 38 others. ECHO THERAPEUTICS is the single largest importer with 21 shipments valued at $1.1M USD.

India's hydrocortisone exports to Australia are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 46 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 13 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED , MEPRO PHARMACEUTICALS PRIVATE LIMITED — together account for 89% of total trade value on this route. The average shipment value of $22.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as cipla hydrocortisone 100mg injection(hyd and cipla hydrocortisone 100mg injectionhydrocortisone sodium succinate injection 100mg5864 packx5=29320 nos5ml vial1, suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ECHO THERAPEUTICS is the largest importer with 21 shipments worth $1.1M USD — representing 40% of all hydrocortisone imports from India on this route. A total of 41 buyers are active on this corridor.